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Polymorphisms in Interleukin-15 Gene on
Chromosome 4q31.2 Are Associated with Psoriasis
Vulgaris in Chinese Population
Xue-Jun Zhang1,2,6, Kai-Lin Yan1,2, Zhi-Min Wang3,4, Sen Yang1,2, Guo-Long Zhang1,2, Xing Fan1,2,
Feng-Li Xiao1,2, Min Gao1,2, Yong Cui1,2, Pei-Guang Wang1,2, Liang-dan Sun1,2, Kai-Yue Zhang3,
Beilan Wang1,2,3,4,5, Da-Zhi Wang3, Shi-Jie Xu3, Wei Huang3,6 and Jian-Jun Liu1,2,5
Through a series of linkage analyses in a large Chinese family cohort of psoriasis, we previously identified and
confirmed a non-HLA psoriasis linkage locus PSORS9 within a small region at 4q31.2–32.1. Within the critical
region of the PSORS9 locus, IL-15 has been long recognized as a strong candidate gene for psoriasis. In this
study, we investigated the association between IL-15 genetic polymorphisms and psoriasis in a large Chinese
sample. Highly significant evidence for association was identified at a single-nucleotide polymorphism (SNP)
(g.96516A-T) within the 30-untranslated region (UTR) of the IL-15 gene (P¼ 0.00006, after correction for multiple
testing). Haplotype analysis using the SNPs within the 30UTR region also provided strong supporting evidence
for association (P¼ 0.00005), where we identified a haplotype of the 30UTR region of IL-15 associated with
increased risk to psoriasis (odds ratio¼ 1.65). This association was also supported by the results of our
expression activity analyses, where we demonstrated that the identified risk haplotype is associated with an
increased activity of IL-15. Therefore, we provided early evidence for the important role of IL-15 genetic variants
in the pathogenesis of psoriasis, probably by increasing interleukin production and inflammation in the lesions
of psoriasis.
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INTRODUCTION
Psoriasis (OMIM *177900) is recognized as the most prevalent
autoimmune disease caused by inappropriate activation of the
cellular immune system that has a prevalence of 2–5% in
Caucasian populations (Nevitt and Hutchinson, 1996) and
0.1–0.3% in Far East populations (Simons, 1949; Yui, 1984). It
is characterized by scaly skin patches caused by the infiltration
of inflammatory cells into dermis and epidermis, with secon-
dary keratinocyte hyperproliferation (Bowcock and Krueger,
2005). Epidemiological and family studies (Bhalerao and
Bowcock, 1998) have clearly demonstrated a strong genetic
component to the risk to psoriasis, and a combination of
genetic and environmental factors is believed to be causative.
Many groups around the world have pursued the search for
disease gene using linkage analysis in large family cohorts
(Tomfohrde et al., 1994; Matthews et al., 1996; Nair et al.,
1997; Trembath et al., 1997; Capon et al., 1999; Samuelsson
et al., 1999; Lee et al., 2000; Veal et al., 2001; Zhang et al.,
2002; Asumalahti et al., 2003; Karason et al., 2005), and nine
loci designated PSORS1–9 as well as additional 11 loci have
been identified or been suggested as psoriasis susceptibility
loci. Despite a major international effort, no susceptibility
genes have been identified with certainty till today.
In our previously genome-wide scan (Zhang et al., 2002),
we localized a non-HLA psoriasis susceptibility locus to
chromosome 4q28–q32 (PSORS9) in 61 multiply affected
families. The linkage was supported by a subsequent meta-
analysis of five genome-wide linkage data, showing that apart
from the major linkage locus within the HLA region (PSORS1)
on chromosome 6p, the 4q31 interval is another major
linkage locus for psoriasis (Sagoo et al., 2004). Recently, we
performed a followed-up study using an extended Chinese
family cohort of psoriasis and dense marker coverage, which
confirmed and refined the PSORS9 locus to a small region at
4q31.2–32.1 (Yan et al., 2007).
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IL-15 has been recognized as one of the candidate genes
within the critical region of the PSORS9 locus (Bowcock,
2004). IL-15 is a Th1-related cytokine that triggers inflam-
matory cell recruitment, angiogenesis, and production of
other inflammatory cytokines. An upregulated IL-15 expres-
sion is consistently reported in psoriatic lesions (Ong et al.,
2002; Ruckert et al., 2003). Psoriatic dermal pathology is
characterized by local T cell, macrophage and neutrophil
infiltration and activation, angiogenesis, and epidermal
hyperplasia, all features to which IL-15 might plausibly
contribute (McInnes and Gracie, 2004). Villadsen et al.
(2003) identified that an IL-15-specific antibody reduced the
severity of psoriasis in a human psoriasis xenograft model.
In this study, we investigate the possibility of IL-15 being a
susceptibility gene within the PSORS9 locus through a series
of genetic and functional analyses in a large Chinese sample
of psoriasis.
RESULTS
Sequence analysis of IL-15
We first performed a systematic sequence analysis of IL-15 by
analyzing all eight known exons, exon–intron boundaries,
approximately 2,000 bp upstream of the 50 flank and down-
stream of the 30 flank sequences in 48 affected individuals of
psoriasis and 48 healthy controls. We identified 19 variants,
of which 14 are known variants (rs4956403, rs3806798,
rs2857261, rs9282742, rs4956406, rs1021446, rs3775596,
rs12508335, rs7349640, rs12510030, rs17007610,
rs10519613, rs1057972, and rs10833) and five are novel
ones (1216A/G, 82704T/C, 82705T/C, 96516A/T, and
99717G/T) (Table 1). Nucleotide position one (þ1) is the
first basepair of the exon 1(NM_172174). The novel single-
nucleotide polymorphisms (SNPs) are named g.xxxx, where
the xxx stands for the position of the SNP on the reference
sequence NM_172174. None of the identified variants is in
the coding sequences or potential splicing sites of IL-15.
Linkage disequilibrium pattern characterization
In order to perform a comprehensive genetic association
analysis of IL-15, we characterized the linkage disequilibrium
(LD) pattern within IL-15. Aiming to achieve a dense and
even SNP coverage across the whole gene, without any gap
larger than 5 kb, additional 19 SNPs were selected from the
public dbSNP database (nine from database) or identified
by additional sequence analysis in the same 48 cases and
48 healthy controls (10 from sequence analysis). In total, we
analyzed 38 SNPs in the 48 cases and 48 health controls: five
variants in the 50-flanking region, four in the 30-untranslated
region (UTR), 28 within introns, and one in 30-flanking region
(Table 1). All the 38 variants have an estimated minor allele
frequency above 5%. The 38 SNPs spanned a total of 100 kb
sequence of the entire IL-15 gene, resulting in dense coverage
of one SNP per 3 kb sequence. Based on the genotypes from
the 48 cases and 48 healthy controls, none of the SNPs
showed a significant deviation (Po0.05) from Hardy–Wein-
berg equilibrium.
LD pattern was characterized by calculating pairwise
D0 and r2 values among 38 SNPs and summarized in Figure 1.
Strong LD was observed across the IL-15 gene region, and at
least one historical recombination seems to have occurred,
dividing the region into two strong LD blocks. Such a pattern
is very similar to the one of Chinese population from the
HapMap project (data not shown). In order to perform
an effective and efficient genetic association analysis,
tagging SNP-based approach was employed by selecting
12 representative SNPs (g.-1216, rs12508866, rs13106911,
rs7671458, rs2322301, g.82704, rs2857261, rs10519613,
g.96516, rs1057972, rs10833, and g.99717) using r2¼0.9 as
a cut-off value, that is, the genetic association analysis using
the 12 selected SNPs will only suffer a slight lose of power
comparing with an analysis using all the 38 SNPs.
Case–control association analysis
We performed a case–control association analysis of IL-15
common genetic variations by genotyping the 12 selected
SNPs in a sample of 632 unrelated psoriatic patients and 485
healthy controls. The genotypes of the 12 SNPs were all in
Hardy–Weinberg equilibrium in both case and control groups
(P40.05). For association analysis, we first tested each of the
12 SNPs individually for association with disease phenotype.
Of the 12 SNPs tested, four SNPs (rs2857261, rs10519613,
g.96516, and rs1057972) showed significant association to
psoriasis with a nominal P-value below 0.05 (Table 2). The
four SNPs spanned 13.9 kb sequence of IL-15, one within
intron 3 and the other three in the 30UTR region of the gene.
After a Bonferroni correction for multiple testing, only two
SNPs (rs10519613 and g.96516) from the 30UTR region still
showed significant association with disease phenotype
(P¼0.048 and 0.00006, respectively). The most significant
association evidence was detected at the SNP g.96516A-T,
where the T allele was associated with increased risk
to psoriasis (odds ratio (OR)¼ 1.56) at a highly significant
P-value (P¼0.000005) (Table 2). Furthermore, under a domi-
nant model, the evidence for association is even stronger with
a higher OR value and a smaller P-value (P¼ 0.0000004;
OR¼1.86) (Table 2).
We further investigated the association evidence within
the 30UTR region by analyzing the haplotypes of the four
SNPs showing positive association evidence. The haplotypes
of the four SNPs were constructed from unphased genotype
data using the PHASE program. A total of seven haplotypes
was identified, but only four haplotypes are common, with
a population frequency above 10% and accounted for
87.4% of all the observed haplotypes (Table 3). All the
seven haplotypes were tested for association with disease
phenotype, and two haplotypes showed significant asso-
ciation evidence, with a nominal Po0.05 (Table 3). A highly
significant evidence for association was obtained for the
haplotype 4, with a nominal P¼0.00005, which remained
highly significant after a Bonferroni correction for multiple
testing. This haplotype (ATAC) has a population frequency of
18.1% in affected individuals but 10.9% in healthy controls
(Table 3). The estimated relative risk conferred by this
haplotype was 1.65 under an assumption of a multiplicative
model. When the haplotypes had been taken into account
under a dominant model, we did find the distribution of
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haplotype 3 (P¼ 0.037; OR¼1.39; 95% confidence
interval 1.018–1.894) and haplotype 4 (P¼ 0.000016;
OR¼1.88; 95% confidence interval 1.408–2.507) differed
significantly between the psoriatic and control groups in our
samples. The haplotypes 3 and 4 both showed a higher
frequency in cases than in controls. All the haplotypes
that were significantly associated with a P-value less
than 0.05 were highly correlated with susceptibility T allele
of SNP g.96516A-T and may indicate susceptibility to
psoriasis.
Table 1. Characteristics of the polymorphisms that were detected in the IL-15 gene
Number RefSNP ID Position1 Variation Location Minor allele frequency Primers
1 Novel 1216 A/G 50 flank 0.175 F2R2
2 rs4956403 831 C/T 50 flank 0.047 F3R3
3 rs3806798 475 T/A 50 flank 0.156 F3R3
4 rs12508866 7939 T/C Intron 1 0.215 F7R7
5 rs11946791 8531 A/G Intron 1 0.346 F7R7
6 rs1519551 12718 A/G Intron 1 0.222 F8R8
7 rs9790346 12767 G/T Intron 1 0.085 F8R8
8 rs957077 22062 T/C Intron 2 0.111 F10R10
9 rs1808109 22414 C/T Intron 2 0.096 F10R10
10 Novel 30412 C/A Intron 2 0.178 F11R11
11 rs932209 30693 G/A Intron 2 0.205 F11R11
12 Novel 30887 T/C Intron 2 0.026 F11R11
13 rs2090664 39838 C/T Intron 2 0.222 F12R12
14 rs13104121 39938 A/C Intron 2 0.054 F12R12
15 Novel 45025 A/T Intron 2 0.096 F13R13
16 rs12498901 45376 G/C Intron 2 0.136 F13R13
17 rs13106911 57991 C/T Intron 2 0.419 F14R14
18 rs13112582 58252 C/T Intron 2 0.378 F14R14
19 rs13139573 58440 A/T Intron 2 0.378 F14R14
20 rs7671458 69707 T/G Intron 2 0.156 F15R15
21 rs1607595 77894 C/T Intron 2 0.156 F16R16
22 rs2322301 78559 C/T Intron 2 0.378 F16R16
23 Novel 82704 T/C Intron 2 0.173 F17R17
24 Novel 82705 T/C Intron 2 0.173 F17R17
25 rs2857261 82883 A/G Intron 3 0.364 F17R17
26 rs9282742 83020 T/C Intron 3 0.432 F17R17
27 rs4956406 84051 G/A Intron 4 0.398 F18R18
28 rs1021446 90803 A/G Intron 5 0.444 F20R20
29 rs3775596 92060 A/C Intron 6 0.455 F20R20
30 rs12508335 93114 A/G Intron 6 0.415 F21R21
31 rs7349640 93147 A/G Intron 6 0.176 F21R21
32 rs12510030 93405 T/C Intron 7 0.415 F21R21
33 rs17007610 93511 T/C Intron 7 0.415 F21R21
34 rs10519613 96330 C/A 30UTR 0.419 F22R22
35 Novel 96516 A/T 30UTR 0.265 F22R22
36 rs1057972 96678 A/T 30UTR 0.487 F22R22
37 rs10833 96793 C/T 30UTR 0.057 F22R22
38 Novel 99717 G/T 30 flank 0.215 F23R23
1Nucleotide position one (+1) is the first base pair of the exon 1 (NM_172174).
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Effect of 30UTR of IL-15 gene on luciferase activity
To investigate the impact of the haplotype sequences of
30UTR region on transcriptional activity, we performed a
luciferase activity assay. We transfected the luciferase
reporter constructs carrying the different haplotypes of the
30UTR region, as well as the construct without insert (pGL3-
Hap1, Hap3, Hap4, and pGL3 promoter) into the Jurkat
cells. Among the three transfected haplotypes, the haplotype
1(Hap1) is the most common haplotype observed in Chinese
population and not associated with the increased risk to
psoriasis, whereas haplotypes 3 and 4 (Hap3 and Hap4) are
both associated with psoriasis risk. Luciferase activity analysis
indicated that the luciferase activities of the Jurkat cells
carrying either the pGL3-Hap4 (2.1270.20) or the pGL3-
Hap3 construct (1.8670.09) are significantly higher than
those of the cells carrying the non-risk haplotype 1 (pGL3-
Hap1, 1.3970.21) (Po0.01). The luciferase activities of the
cells carrying the pGL3-Hap3 and pGL3-Hap4 constructs are
33.9 and 52.9% higher than the activity of the cells carrying
pGL3-Hap1 construct, respectively (see Table 4). Of interest,
the haplotype 4, which showed a stronger association with
psoriasis than the haplotype 3, also showed a stronger
induction of luciferase activity than the haplotype 3.
DISCUSSION
In this study, we investigated the contribution of IL-15 genetic
polymorphisms to the development of psoriasis. First, we
sequenced the coding, exon–intron boundary and promoter
sequences of IL-15 in 48 psoriatic cases and 48 controls, but
did not identify any putative functional polymorphisms that
might have a role in disease development. To further evaluate
the role of other IL-15 genetic polymorphisms, we subse-
quently performed an efficient genetic association analysis
of IL-15 common genetic variants using a tagging SNP-
based approach and identified significant evidence for
association within the 30UTR region of IL-15. Both single
SNP- and haplotype-based genetic association analyses
provided highly significant evidence that the genotypes and
haplotypes of the SNPs within the 30UTR region of IL-15 are
strongly associated with increased risk to psoriasis. Further-
more, the results of our transcriptional activity analysis using
both luciferase reporter assay and immunohistological stain-
ing analysis suggested that the identified risk haplotypes
(Hap3 and Hap4) are associated with higher expression
activity of IL-15 than the non-risk haplotype (Hap1), and
psoriatic lesion skin shows much higher expression activity
of IL-15 than the non-lesion skin of psoriasis, as well as the
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Figure 1. Pattern of LD within IL-15; the numbers on the x-axis correspond to 38 markers selected to cover the IL-15 gene relatively evenly at an average
spacing of 3 kb. D0 values are shown in the bottom left and r2 values are shown in the top right triangle.
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normal skin. Interestingly, the strength of the association
between the haplotypes of the 30UTR region and disease
phenotype seems to be correlated with the strength of the
luciferase activity induction of the haplotypes. Therefore, our
initial genetic association and subsequent functional analyses
provided first evidence for association between the genetic
variants of IL-15 and risk to psoriasis.
The biological functions of IL-15 support its role as a
predisposition gene to psoriasis. Recent evidence indicates
that the epidermal changes in psoriasis occur in response to
cellular immune infiltrates in the skin, leading to the current
general consensus that psoriasis is a T-cell-mediated inflam-
matory disease. T cells and dendritic cells, together with the
proinflammatory cytokines and chemokines that they secrete,
collaborate to create a proinflammatory environment in
the skin that in turn stimulates the proliferation of resident
keratinocytes and endothelial cells, producing a pattern of
tissue growth that is recognized as psoriasis (Bowcock and
Krueger, 2005). The proinflammatory action of IL-15 includes
upregulating the cytokines tumor necrosis factor-a, inter-
feron-g, granulocyte colony-stimulating factor, macrophage
Table 2. Summary of the association of Tag SNPs between cases and controls
Genotype
Case Control Allele 1 versus allele 2 Genotype 1/1 vs 1/2+2/2
SNP ID 1/1 1/2 2/2
Minor allele
frequency 1/1 1/2 2/2
Minor allele
frequency
Odds ratio
(95% CI) v2 P-value
Odds ratio
(95% CI) v2 P-value
g.-1216 487 128 17 0.128 360 112 13 0.142 1.13 (0.88–1.44) 0.94 0.333 1.17 (0.89–1.54) 1.20 0.273
Rs12508866 448 164 20 0.161 325 144 16 0.181 1.15 (0.92–1.44) 1.56 0.211 1.20 (0.93–1.55) 1.93 0.164
Rs13106911 239 275 118 0.404 166 239 80 0.411 1.03 (0.87–1.22) 0.11 0.736 1.17 (0.91–1.50) 1.53 0.216
Rs7671458 473 138 21 0.142 342 131 12 0.160 1.15 (0.91–1.45) 1.30 0.254 1.24 (0.95–1.62) 2.60 0.107
Rs2322301 290 268 74 0.329 195 232 58 0.359 1.14 (0.96–1.36) 2.14 0.143 1.26 (0.99–1.66) 3.60 0.058
g.82704 534 89 9 0.085 425 55 5 0.067 0.78 (0.56–1.07) 2.40 0.121 0.77 (0.54–1.09) 2.22 0.136
Rs2857261 291 267 74 0.328 201 209 75 0.370 1.20 (1.01–1.43) 4.23 0.040 1.21 (0.95–1.53) 2.36 0.125
Rs10519613 172 296 164 0.494 168 215 102 0.432 1.28 (1.0841.52) 8.40 0.004 1.42 (1.10–1.83) 7.14 0.008
g.96516 311 238 83 0.320 312 121 52 0.232 1.56 (1.29–1.88) 20.85 0.000005 1.86 (1.46–2.37) 25.44 0.0000004
Rs1057972 165 314 153 0.491 115 226 144 0.470 0.85 (0.72–1.01) 4.89 0.027 1.14 (0.86–1.50) 0.84 0.360
Rs10833 538 88 6 0.079 417 64 4 0.074 0.93 (0.68–1.28) 0.18 0.67 0.93 (0.66–1.31) 0.16 0.688
g.99717 417 195 20 0.186 329 145 11 0.172 0.91 (0.73–1.13) 0.70 0.402 0.92 (0.72–1.18) 0.43 0.514
CI, confidence interval; SNP, single-nucleotide polymorphism.
For each SNP, we named ‘‘1/1’’ the homozygous wild-type genotype, ‘‘2/2’’ the homozygous mutated genotype, and ‘‘1/2’’ the heterozygous genotype.
In each test, a Po0.05 was considered statistically significant.
Table 3. Haplotype structure of 30UTR and their frequencies
SNP ID Haplotype frequency
Haplotype ID rs10519613 g.96516 rs1057972 rs10833 Case (n=632) Control (n=485) v2 P-value Odds ratio (95% CI)
Haplotype 1 C A T C 0.293 0.323 1.314 0.252 0.904 (0.761–1.074)
Haplotype 2 A A A C 0.249 0.243 0.047 0.866 1.021 (0.846–1.233)
Haplotype 3 C T T C 0.151 0.118 3.919 0.048 1.281 (1.002–1.638)
Haplotype 4 A T A C 0.181 0.109 16.292 0.00005 1.651 (1.292–2.109)
Haplotype 5 C A A T 0.044 0.054 0.936 0.333 0.826 (0.561–1.217)
Haplotype 6 A A T C 0.045 0.064 3.458 0.063 0.706 (0.488–1.021)
Haplotype 7 C A A C 0.037 0.054 3.193 0.074 0.694 (0.463–1.038)
CI, confidence interval; UTR, untranslated region.
Table 4. The mean difference with relative luciferase
activity one-way ANOVA
VAR00002 VAR00002 Mean difference SE Sig.
pGL3-Hap1 pGL3-Hap3 0.47 0.13 0.0048
pGL3-Hap4 0.73 0.13 0.00026
pGL3-Hap3 pGL3-Hap4 0.26 0.13 0.068
ANOVA, analysis of variance.
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inflammatory protein-1a, and macrophage inflammatory
protein-1b, IL-1b, IL-10 (Fehniger and Caligiuri, 2001).
IL-15 also activates human neutrophils, with effects including
morphologic changes, increased phagocytosis, increased
de novo RNA and protein synthesis, and delayed apoptosis
(Girard et al., 1996). Multiple positive disease associations
have recently been described, with increased expression of
IL-15 protein appearing to be critical to disease pathogenesis
(D’Auria et al., 1999; Asadullah et al., 2000; Muro
et al., 2001; Gonzalez-Alvaro et al., 2003; Shi et al., 2004).
Specifically, with respect to psoriasis, the use of monoclonal
antibodies (146B7) to block the actions of IL-15 results in an
inhibition of the onset in a human psoriasis xenograft model
(Villadsen et al., 2003). In addition, Yano et al. (2003) have
also provided further insight into the mechanisms by
which IL-15-mediated rescue from apoptosis could operate
to promote epidermal proliferation in psoriasis. Complemen-
tary to these biological and pharmacological findings, our
results provide the first genetic evidence for the association
between IL-15 and the development of psoriasis.
Our results show that genetic variants within the 30UTR
region of IL-15 are associated with greater risk to psoriasis by
regulating IL-15 expression activity. This observation was
supported by the results of our in vitro transfection experi-
ments using reporter constructs containing IL-15 30UTR
variants, as well as by the results from our immunohistolo-
gical staining analysis (data no shown), which is similar to a
previous report (Ruckert et al., 2000). The 30UTR region of
genes has been recognized as important for controlling gene
expression activity at different levels such as nuclear export,
polyadenylation, translation efficiency, and mRNA degrada-
tion (Conne et al., 2000; Guhaniyogi and Brewer, 2001;
Macdonald, 2001). It has also shown that from fungus to
human, the 30UTR sequences of genes evolve more rapidly
and thus become more complex than the 50UTR sequences
(Mazumder et al., 2003), suggesting that the 30UTR region
probably carries more important genetic information than
previously thought. Some human diseases, for example,
myotonic dystrophy, have been shown due to mutations in
the 30UTR of genes (Conne et al., 2000). Interestingly, using
multilocus haplotype analysis, Kurz et al. (2004) identified a
strong association between a haplotype covering the 30UTR
of IL-15 and the susceptibility to asthma in German
population. Although indirect, these results provided support-
ing evidence for a functional role of the 30UTR region in
regulating IL-15 activity.
To investigate whether any of the risk-associated SNPs
within the 30UTR region is functional by interrupting or
creating any transcription factor binding sites, we submitted
the sequence containing three SNPs of the 30UTR region of
IL-15 to the ‘‘Genomatix’’ online program (http://www.
genomatix.de/online_help/help_matinspector). The analysis
did not identify any transcription factor-binding sites that
overlap with the SNPs (data not shown). Although we cannot
totally rule out the possibility of the risk-associated SNPs
being functional ones by interrupting unknown transcription
factor binding sites, we believe that the identified risk-
associated SNPs are more likely to be polymorphisms that are
in strong LD with the causal variant for disease. Although the
pathogenic variant within IL-15 is still unknown, our results
suggest that the pathogenic variant will increase the risk to
disease by increasing interleukin production and inflamma-
tion in the lesions of psoriasis.
In conclusion, our studies suggest that IL-15 is a potentially
important gene in psoriasis susceptibility in the Chinese
populations, and that IL-15 polymorphism may contribute to
the development of psoriasis by increasing the expression
level of IL-15. Further studies will be needed to replicate this
associations in additional samples of both Chinese and non-
Chinese populations. Our study provides further support for a
pharmacological inhibition of IL-15 as a mean to treat and
prevent the development of psoriasis.
MATERIALS AND METHODS
Study subjects
We recruited a total of 632 (297 females and 341 males) individuals
affected with psoriasis vulgaris and 485 population-based (225
females and 274 males) unaffected controls for collection of
genomic DNA from the Dermatology Departments of the Anhui
Medical University using an ascertainment procedure described
previously (Zhang et al., 2002). The mean age of the 638 case
individuals with psoriasis was 45.3 years (range, 3–75 years). Control
subjects comprised 485 individuals from the general population
with mean age 39.4 years (range, 13–69 years). All the partici-
pating individuals provided informed written consent. The study
was approved by the Ethics Committee of the Anhui Medical
University and was conducted according to Declaration of Helsinki
Principles.
SNP identification and genotyping
Genomic DNA was extracted from peripheral blood leukocytes
using a standard procedure (Miller et al., 1988). Primers for
sequencing and SNP genotyping analysis were designed using
Primer 3.0 software (http://www:genome.wi.mit.edu/cgi-bin/primer/
primer3/www.cgi) and the genomic sequence NM_172174 from the
GenBank (http://www.ncbi.nlm.nih.gov). All the primer sequences
are listed in the Tables S1 and S2. Sequence analysis was performed
as previously described (Zhang et al., 2004).
We identified the SNPs by sequencing the exons, exon–intron
boundaries and approximately 2000 bp of its putative promoter, and
2 kb downstream from the 30 end in 48 psoriasis vulgaris individuals
and 48 matched healthy controls. We also aimed to cover the genes
with evenly spaced SNPs, avoiding gaps larger than 5 kb within a
gene. Then we detected some public polymorphisms by BLAST
search of the National Center for Biotechnology Information SNP
database.
Assay of IL-15 30UTR
It is accepted that some variants in 30UTRs may be responsible for
complex disease, and they are more likely to be involved in RNA
stability or regulation of translation (possibly through binding of
micro RNAs). We performed luciferase assays to evaluate whether
the SNPs at the IL-15 30UTR influence expression. As there was no
difference distribution in cases and controls, the Hap2 was excluded
for further analysis. 30UTRs of human IL-15 containing the three
kinds of haplotypes, Hap1, Hap3, and Hap4, were subcloned
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into the pGL3 promoter luciferase vector (Promega, Madison, WI).
The target segments corresponding to Hap1, Hap3, and Hap4
were amplified by PCR using genotype-known genomic DNAs
as templates; primers for this procedure were the upstream primer
50-GCtctagaTAGACATAACAAAACACTC-30 and downstream primer
50- GCtctagaATTGCAATTTCTTTATTTCA-30 (lower case including
XbaI restriction site). PCR products were digested with XbaI (New
England Biolabs). Colonies were screened by direct PCR using
the forward primer IL-15 30UTR s-f 50-CGTCGCCAGTCAAGTAAC
AA-30and the reverse primer IL-15 30UTR s-r 50-TGGTTTGTCCAA
ACTCATCA-30, and just the colonies with right insert direction can
get productions. After sequencing, we get the positive colonies those
called pGL-Hap1, pGL-Hap3, and pGL-Hap4. The positive plasmids
DNA isolated with a QIAGENs plasmid Midi kit (Qiagen, Hilden,
Germany).
We found IL-15 has high expression level in leukocyte, so the
Jurkat cell line was selected. The plasmids were transfected into
Jurkat cells by the Superfectant transfection reagent (Qiagen).
All cells were collected 48 hours later after transient transfection
and the lysate was analyzed for luciferase activity with Microlumet
Plus LB 96 V (Berthold Technologies, Bad Wildbach, Germany)
using luciferase assay reagent (Promega, TM046) following the
manufacturer’s protocol. At least three independent experiments
of transfection were performed.
Statistical analysis
LD pattern was characterized by calculating pairwise D0 values
using the Linkage Disequilibrium Analyzer 1.0 software (Ding et al.,
2003). Haploview 3.2 was used to generate the LD plot (Barrett
et al., 2005) (http://www.broad.mit.edu/mpg/haploview/). All the
genotyping data were tested for Hardy–Weinberg equilibrium.
Case–control association analysis was performed by using both
SNP genotypes and haplotypes. Genotype frequency difference
between cases and controls was tested using a two-sided Pearson’s
w2 test. Haplotype-based association analysis was performed using
the program PHASE 2.0 (Stephens et al., 2001), where haplotypes
were first constructed from unphased genotypes using the EM
algorithm, and haplotype frequency difference between cases and
controls was then tested by permutation of 1000 times. A P-value
less than 0.05 was considered statistically significant. Statistical
analysis was performed with the SPSS 10.0 software.
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